/ News, Research, People
The Christofori lab discovered a novel combination therapy, which triggers a conversion of malignant breast cancer cells into fat cells.
The researchers took advantage of the property of tumor cells to adapt dynamically to changing conditions. Using two established drugs, they could re-differentiate cancer cells to non-dividing fat cells.
The therapy fully prevented the formation of metastases in mice, as recently reported in the journal Cancer Cell.